Cigna Group (NYSE:CI – Get Free Report) insider Nicole Jones sold 2,677 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the transaction, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Cigna Group Stock Performance
NYSE CI opened at $276.19 on Friday. The company has a fifty day simple moving average of $284.20 and a 200 day simple moving average of $281.38. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $72.98 billion, a P/E ratio of 11.43, a PEG ratio of 0.94 and a beta of 0.29.
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the prior year, the company posted $7.20 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
Analysts Set New Price Targets
Several equities analysts have weighed in on CI shares. Royal Bank Of Canada raised their price objective on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Wolfe Research reiterated an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a research note on Tuesday, June 16th. Deutsche Bank Aktiengesellschaft downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Morgan Stanley raised their price target on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. Finally, Mizuho boosted their price target on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.
View Our Latest Research Report on Cigna Group
Institutional Investors Weigh In On Cigna Group
Institutional investors have recently added to or reduced their stakes in the business. United Community Bank lifted its position in shares of Cigna Group by 93.0% during the second quarter. United Community Bank now owns 1,245 shares of the health services provider’s stock worth $343,000 after acquiring an additional 600 shares in the last quarter. NEOS Investment Management LLC grew its position in shares of Cigna Group by 12.4% in the second quarter. NEOS Investment Management LLC now owns 42,905 shares of the health services provider’s stock valued at $11,828,000 after purchasing an additional 4,727 shares in the last quarter. Continuum Advisory LLC raised its stake in shares of Cigna Group by 0.3% during the 2nd quarter. Continuum Advisory LLC now owns 19,633 shares of the health services provider’s stock valued at $5,412,000 after purchasing an additional 68 shares during the period. Nykredit A S bought a new stake in shares of Cigna Group during the 2nd quarter valued at $17,257,000. Finally, B. Metzler seel. Sohn & Co. AG lifted its holdings in Cigna Group by 10.8% during the 2nd quarter. B. Metzler seel. Sohn & Co. AG now owns 35,312 shares of the health services provider’s stock worth $9,735,000 after purchasing an additional 3,431 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
- Five stocks we like better than Cigna Group
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
